Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,876 total articles
Smithfield Foods, a major American packaged meats company, declared a quarterly dividend of $0.3125 per share, payable on May 28, 2026, to shareholders of record by May 14, 2026. This move reflects the company's stable financial position and commitment to returning value to its investors.
Bakkt, Inc. has completed its acquisition of Distributed Technologies Research (DTR), combining Bakkt's regulated financial infrastructure with DTR’s AI-native payments and stablecoin technology. This merger aims to build a unified platform offering 24/7 digital settlement capabilities, targeting over $44 trillion in cross-border payments by enabli…
TELA Bio, a NASDAQ-listed commercial-stage medical technology company specializing in soft-tissue reconstruction, announced a strategic refresh of its Board of Directors with four new commercial leaders to enhance growth and operational excellence. The company also reported preliminary Q1 2026 revenues of approximately $19 million, surpassing prior…
Xos, Inc., an electric truck manufacturer and fleet services provider, announced it will release its Q1 2026 financial results on May 14, 2026, after market close. The company will host a conference call to discuss the results. The announcement outlines forward-looking statements and associated risks related to business plans, supply chain, competi…
UMH Properties, Inc. announced its Q1 2026 financial results showing an 8% increase in total income to $65.8 million, a return to net income of $2.6 million from a loss in the prior year, and stable normalized funds from operations. The company saw higher rental income, improved occupancy rates, and issued preferred stock to fund growth, while expe…
Twin Disc, Inc. announced a quarterly cash dividend of $0.04 per share, payable on June 1, 2026, signaling strong financial health and commitment to shareholder returns. The company specializes in marine and heavy-duty power transmission equipment serving various sectors including marine, energy, and industrial markets.
Alvotech, a Nasdaq-listed global biotech company specializing in biosimilars, announced that General Counsel Tanya Zharov will step down after six years. Zharov contributed to multiple public listings and team building, and will support a smooth handover while remaining engaged with affiliated holding companies. The company emphasizes its ongoing g…
Monolithic Power Systems (MPWR) successfully defended against a patent infringement lawsuit filed by Bel Power Solutions in the U.S. District Court for the Western District of Texas. The court granted summary judgment of non-infringement on all claims, resulting in dismissal of the case. Additionally, four of Bel Power's patents were canceled follo…
Cal-Maine Foods, the largest egg company in the U.S., announced its management's participation in upcoming investor conferences including Goldman Sachs Global Staples Forum, BMO Global Farm to Market Conference, and the 2026 Benchmark Consumer 1x1 Investor Conference. Presentations and materials will be available on the company's investor relations…
DBV Technologies reported its first quarter 2026 financial results, emphasizing progress toward Biologics License Application (BLA) filings for its VIASKIN® Peanut Patch targeting peanut-allergic children aged 4 to 7 and toddlers 1 to 3 years. The company holds $229 million in cash and cash equivalents, sufficient to fund operations into Q2 2027, b…
Collective Acquisition Corp. II completed its initial public offering of 22 million units at $10 per unit, raising $220 million. The units started trading on Nasdaq under the ticker CAIIU. As a blank check company, it intends to seek acquisition opportunities primarily in sectors related to U.S. national interests including financial, strategic res…
Recursion, a clinical-stage TechBio company focused on AI-driven drug discovery, announced that its founder Chris Gibson, Ph.D., will not seek re-election to the Board of Directors after June 2026 but will continue as a strategic advisor. The company emphasizes continuity and long-term value creation under CEO Najat Khan's leadership, advancing its…
Emergent BioSolutions Inc. announced its Q1 2026 financial results, reporting total revenues of $156.1 million, net income of $6.8 million, and adjusted EBITDA of $35.6 million. While revenues exceeded guidance, they declined 30% year-over-year, driven by lower sales in key biodefense medical countermeasure segments. The company secured new partner…
Home Federal Bancorp, Inc. of Louisiana reported significant increases in net income and earnings per share for the three and nine months ended March 31, 2026, driven by improved net interest margins, increased net interest income, and decreased non-interest expenses. The company also expanded its assets and deposits, while continuing its stock rep…
Cue Biopharma announced a $30 million private placement (PIPE financing) through the sale of pre-funded warrants and common stock warrants, aimed at advancing its clinical pipeline, including the development of Ascendant-221, as well as supporting working capital and general corporate purposes. The financing is expected to close in early May 2026, …
Canadian National Railway Company (CN) issued a statement opposing the amended merger application of Union Pacific and Norfolk Southern, arguing that it fails to adequately address the competitive harms posed by the merger and lacks meaningful remedies as required by the Surface Transportation Board. CN emphasizes the need for strict regulatory con…
HCW Biologics Inc. announced the adjournment of its Special Meeting of Stockholders held on April 27, 2026, due to insufficient quorum, postponing the approval of proposals regarding warrants issued to Armistice Capital Master Fund Ltd. The matters will be addressed at the Annual Meeting scheduled for June 15, 2026. This ongoing delay obliges the c…
Tejon Ranch Co., a diversified real estate development and agribusiness company, announced it will release its Q1 2026 financial results before market open on May 7, 2026, followed by a conference call with executives to discuss recent initiatives and results. The call will be webcast and accessible to investors with Q&A submitted in advance.
Evolution Petroleum Corporation announced its plan to release the fiscal third quarter 2026 financial and operating results on May 12, 2026, followed by a conference call with top executives on May 13, 2026. The company focuses on U.S. onshore oil and natural gas properties, aiming to maximize shareholder returns through diversified asset managemen…
The Boston Beer Company reported first quarter 2026 results showing a 4% decline in depletions and 6.9% decrease in shipments, with net revenue down 4.4%. Despite gross margin improving 100 basis points to 49.3%, the company incurred a substantial non-recurring pre-tax litigation expense of $216 million, resulting in a GAAP diluted loss per share o…
Ryman Hospitality Properties, Inc. (NYSE: RHP) announced record first quarter 2026 financial results driven by strong performance in its same-store Hospitality segment. The company reported record consolidated revenue of $664.6 million, net income of $69.4 million, and Adjusted EBITDAre of $219.3 million. The hospitality portfolio saw increased boo…
FinWise Bancorp reported Q1 2026 financial results, highlighting $1.7 billion in loan originations, up 38% year-over-year. Net income declined to $2.7 million with diluted EPS of $0.20, compared to previous periods. The quarter saw higher net interest income and margin, driven by growth in credit enhanced loans and strategic programs. However, elev…
Piedmont Realty Trust, a self-managed real estate investment company specializing in Class A office properties in U.S. Sunbelt markets, announced its financial and operational results for Q1 2026. The company has scheduled a conference call and webcast to discuss the quarter's performance and recent developments.
Cue Biopharma has entered an exclusive license agreement to develop and commercialize Ascendant-221, a Phase 2 clinical-stage dual-mechanism anti-IgE monoclonal antibody designed to treat allergic diseases. The company plans a global Phase 2b trial in food allergy after data expected in late 2026 from an ongoing study in chronic spontaneous urticar…
Comstock Inc., a clean energy technology company listed on NYSE American under ticker LODE, will hold its Q1 2026 earnings call and business update webinar on May 7, 2026. The company's CEO and CFO will present financial results and operational updates, followed by a Q&A session. The company focuses on extracting and recycling metals from under-uti…
